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1. Introduction 
Over the last years, an extensive improvement in the use of non-standard kidney allografts 
from deceased donors has been observed due to a chronic scarcity in the number of 
available donors. However, use of these donors seems to give worse results, higher delayed 
graft function (DGF) and rejection rates and briefer graft survivals.  
Nevertheless, a standardized definition of non-standard donor is still under debate.  
On these grounds, several studies have focalized on the importance of events immediately 
before or early post-transplant in determining allograft outcome: introduction of scores 
based on peri-operative features capable to predict graft function may yield huge 
implications for organ allocation policies, as well as for immediate and late clinical and 
immunological management of recipients. In fact, if pre-KT information could accurately 
predict suboptimal early graft function, the success of various mechanical, 
immunosuppressive and organ allocation strategies may be improved. 
The aim of this review is to analyze the different pre- and post-transplant score systems, 
detecting their role in the clinical practice and comparing them in terms of prognostic ability.  
2. Donor quality scoring systems 
In the last decades, several different scoring systems based on donor, recipient and 
transplant parameters have been proposed with the intent to predict early and late post-KT 
graft function.  
Despite several of these scores have been validated on large cohorts or have been adopted 
by national allocation systems, no one of them has been already internationally recognized 
as the best model for graft function prediction.   
We analyzed these scores, stratifying them in three groups according to the different 
parameters by which they are composed: demographic and serological variables, 
histological graft variables, donor and histological graft variables.  
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2.1 Demographic and serological variables  
Several scores exclusively based on donor features or composed by a combination of 
parameters obtained by donor, transplant and donor-recipient match have been created. 
Some of these scores are commonly adopted in the care practice: we reported the most 
commonly used.  
2.1.1 ECD  
In March 2001, a consensus meeting who took place in Crystal City introduced a new 
definition of expanded criteria donor (ECD) (Rosengard et al, 2002). Under the work group’s 
proposed plan, the Organ Procurement and Transplantation Network (OPTN), through its 
contract with the United Network for Organ Sharing (UNOS) developed a standard policy 
for national kidney allocation in the United States. In November 2001, the OPTN/UNOS 
Board of Directors adopted the new ECD definition and the new allocation system became 
operative in October 2002. The new definition of ECD derived from four different donor risk 
factors for graft failure: age, history of hypertension, cerebrovascular accident as a cause of 
death and final pre-procurement creatinine > 1.5 mg/dL. 
Different combinations of these four parameters characterized each donor kidney and a 
relative risk of graft loss was determined for each donor profile (Figure 1).  
 
 
Fig. 1. Relative risks (RR) of graft loss by four donor characteristics. Taken from Metzger et 
al., 2003. 
The ECD kidney was then arbitrarily defined as any kidney whose relative risk of graft 
failure exceeded 1.7 when compared to a reference group of ideal donor kidneys (age 10–39 
years, no hypertension, no cerebrovascular accident as cause of death and terminal 
predonation creatinine level < 1.5 mg/dL).  
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The definition of ECD status is the following (Table 1):  
a. Donor age older than 59 years;  
b. Donor age between 50 and 59 years with, additionally two of the following: death 
caused by cerebrovascular accident (CVA); terminal creatinine more than 1.5 mg/dL; 
history of hypertension. 
 
 Donor age categories (years) 
Donor condition < 10 10-39 40-49 50-59 ≥ 60 
CVA + HTN + Creat > 1.5    X X 
CVA + HTN    X X 
CVA + Creat > 1.5    X X 
HTN + Creat > 1.5    X X 
CVA     X 
HTN     X 
Creat > 1.5     X 
None of the above 
 
    X 
Source: OPTN. 
CVA = cerebrovascular accident was cause of death. 
HTN = history of hypertension. 
Creat > 1.5 = Creatinine > 1,5 mg/dL. 
Table 1. ECD for kidney donors. Taken from Rosengard et al., 2002 (with modifications).  
A multicentre study (Metzger et al., 2003) based on OPTN/SRTR data showed a progressive 
increase in ECD utilization across the years, confirming the worse results obtained from 
these donors in terms of both patient and graft survivals. 
Nevertheless, a more rational definition of ECD has given major opportunities to patients 
who had presented limited access to KT to be transplanted.  
A monocentre analysis (Stratta et al., 2004) reported an effective increased volume of KTs 
within 1 year after the adoption of ECD policy; moreover, the authors observed similar 
results in terms of graft function and morbidity among recipients who received organs from 
standard or ECD. A systematic approach to ECD kidneys based on nephron mass matching 
and nephron sparing measures showed to provide optimal short-term outcomes and renal 
function comparable to standard kidneys. 
2.1.2 DDS  
Using ECD, a better allocation policy was obtained. On the other hand, the binary nature of 
the ECD definition may have underappreciated the variability of the quality of the organ. 
On these grounds, (Nyberg et al., 2001) a more granulated scoring system (deceased donor 
score, DDS) was developed. DDS was based on seven different donor variables easily 
available at the moment of procurement. The end measure for the development of the score 
was the 6-month creatinine clearance value.  
The variables analyzed were:  
Cause of death (0-6 points), history of hypertension (0-6), renal creatinine clearance before 
procurement (0-6), age (0-6), history of diabetes mellitus (0-3), cold ischemia time (0-3) and severity 
of renal artery plaque (0-3).  
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The population enrolled for the study (241 cadaveric KT recipients) was stratified in four 
groups: grade A (0-5 points), grade B (6-10), grade C (11-15) and grade D (16-32). 
Adoption of this score permitted an effective stratification of the population, showing that 
information available at the time of organ harvesting may estimate early graft function after 
cadaveric renal transplantation. 
The same Authors (Nyberg et al., 2003) improved on their original scoring system studying 
the data 34.324 KT patients reported in the OPTN/SRTR registry. The five donor variables 
adopted were: 
Age (0-25 points), history of hypertension (0-4), creatinine clearance before procurement (0-4), cause 
of death (0-3), HLA mismatch (0-3).  
The entire population was stratified in four different grades according to the cumulative 
donor score: grade A (0-9 points), grade B (10-19), grade C (20-29) and grade D (30-39).  
The influence of donor score on both graft function and survival was most severe above 20 
points (Figure 2).  
 
 
Fig. 2. Nyberg score grading significantly influences graft survival after transplantation. The 
greatest 6-year graft survival difference was observed between grades B and C, suggesting a 
cutoff for ‘marginal’ kidneys of approximately 20 points. Taken from Nyberg et al., 2003.  
Afterwards, according to Nyberg score, this threshold value designates “marginal” kidneys.  
2.1.3 DGF nomogram   
According to the most commonly adopted definition, DGF is the need for dialysis in the first 
week after transplantation.  
A multicentre study (Irish et al., 2003) analyzed data obtained from 13.846 patients reported 
in the United States Renal Data System (USRDS) registry from 1995 to 1998. Using a 
multivariable logistic regression analysis, factors contributing to DGF were analyzed.  
The pre-KT donor and recipient factors analyzed were:  
Donor: age, history of hypertension, terminal creatinine, donation after cardiac death, death caused by 
anoxia or CVA; cold ischemia time; HLA mismatch; combined organ transplantation.  
Recipient: gender, race, diabetes, history of previous transplantation, history of transfusion, history of 
dialysis before transplantation, peak panel reactive anti-HLA antibodies. 
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A nomogram quantifying the relative contribution of each risk factor was created, providing 
a useful tool for developing a pretransplantation index of the likelihood of DGF occurrence 
(Figure 3).  
Seven years later, a new analysis (Irish et al., 2010) was performed on 24.337 patients 
transplanted during the period 2003-2006. The authors developed a novel nomogram and a 
web-based calculator (http://www.transplantcalculator.com/DGF) as an easily accessible 
tool for predicting DGF.  
Comparing risk factors in the modern (2003-2006) and in the earlier era (1995-1998), weight 
of immunological factors attenuated, while impact of donor renal function increased by 2-
fold. The most significant factors associated with DGF were cold ischemia time, donor 
creatinine, body mass index, donation after cardiac death and donor age. 
 
 
 
 
 
 
Fig. 3. Nomogram for estimating the risk of delayed graft function (DGF) in adult renal 
transplant recipients. HLAmm, HLA mismatch; S.Cr., serum creatinine; PRA, panel-reactive 
antibody; CIT, cold ischemia time; RR, recipient race; PID, pre-transplantation dialysis; 
DCOD, donor cause of death; SOT, single-organ transplant. Taken from Irish et al., 2003. 
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2.1.4 Pessione score   
A retrospective analysis of a cohort of 7.209 deceased KT recipients transplanted in France 
from 1996 to 2000 was performed and a new scoring system (Pessione et al.. 2003) was 
ideated.  
After multivariate analysis, only three parameters resulted as significant independent risk 
factors for graft failure: 
Cerebrovascular cause of death, history of hypertension and elevated serum creatinine (> 150 
micromol/L). 
Donor age > 60 years was a statistically significant, but dependent, risk factor. The increased 
risk of graft loss in patients who presented the cumulative effect of donor risk factors was 
greater in recipients aged more than 60 years (one risk factor: RR = 1.8; two risk factors: RR 
= 2.7) (Figure 4). 
 
 
Fig. 4. Rate ratios of graft failure according to the absence or the presence of one or >2 
significant donor risk factors in the different recipient age groups. *p-value = 0.008 (vs. 
patients <60 yr), ** p-value = 0.04 (vs. patients <60 yr), *** p-value = NS (vs. patients <60 yr). 
Taken from Pessione et al., 2003.  
2.1.5 DRS   
Donor risk score (DRS) (Schold et al., 2005) represents a model in which not only significant 
donor features, but also donor-recipient matches and cold ischemia time are adopted.    
The variables used for the creation of the score were: 
Donor race; donor history of hypertension; donor history of diabetes; donor death due to CVA; cold 
ischemia time; HLA mismatch; donor/ recipient cytomegalovirus (CMV) match.  
The following grades based on accumulated “points” have been proposed: grade I (0-0.234), 
grade II (0.234-0.524), grade III (0.524-0.853), grade IV (0.853-1.17), and grade V (>1.17). 
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Adopting this model, the projected half-lives by donor grade, calculated utilizing data 
beyond 2-year posttransplant, were: grade I = 10.7 years;  II = 10.0 years;  III = 7.9 years; IV = 
5.7 years; V = 4.5 years. 
Comparing DRS with ECD and Nyberg score, the first one was the best model in graft loss 
stratification (Figure 5). 
 
 
Fig. 5. Multivariate estimates for graft loss by donor grade. *Grade I donor serves as the 
reference group in the model. Taken from Schold et al., 2005. 
2.1.6 KDRI   
Kidney donor risk index (KDRI) (Rao et al., 2009) was proposed as a continuous combining 
donor and transplant variables to quantify graft failure risk. The authors analyzed 69.440 
patients using national data from 1995 to 2005.  
The fourteen proposed KDRI donor and transplant factors, each found to be independently 
associated with graft failure or death, were: 
Donor: age, race, history of hypertension, history of diabetes, serum creatinine, cerebrovascular cause 
of death, height, weight, donation after cardiac death, hepatitis C virus status; 
Transplant: human leukocyte antigen-B and DR mismatch, cold ischemia time, double or en bloc 
transplant.  
The KDRI reflected the rate of graft failure relative to that of a healthy 40-year-old donor. 
Transplants of kidneys in the highest KDRI quintile (>1.45) had an adjusted 5-year graft 
survival of 63%, compared with 82% and 79% in the two lowest KDRI quintiles (<0.79 and 
0.79-<0.96, respectively) (Figure 6).  
2.1.6 DGF score   
An analysis on a monocentre cohort of Italian KTs (Pretagostini et al., 2009) was performed 
with the intent to define the risk factors for the development of DGF.  
The authors found five different donor and transplant parameters most commonly observed 
in non standard donors: 
Donor age ≥ 60 years (P = 0.005), Creatinine Clearance < 40 mL/min (P = 0.025), history of diabetes 
mellitus (P = 0.026), history of hypertension (P = 0.017), and cold ischemia time > 15 hours (P < 
0.0001).  
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Fig. 6. Adjusted graft survival by KDRI quintile. Each survival pertains to a recipient who is 
aged 50 years, non-diabetic, and at the reference level of all other recipient factors. 
Extrapolation was used for the first and second quintile. Taken from Rao et al., 2009. 
2.2 Histological graft variable   
Above clinical features, another adopted approach fo4r the identification of high-risk 
kidneys is to use a pre-KT biopsy in order to characterize potential kidney grafts, help 
predict the graft outcome and provide a reference point for analysis of subsequent biopsies. 
Several different histological parameters have been correlated with poor outcomes (i.e. 
percentage of sclerotic glomerules, degree of tubulointerstitial and chronic vascular lesions).  
Starting from these considerations, all these histological changes were integrated into 
histological scoring systems with the intent to consent a better allocation of kidneys from 
elder donors. All the histological scores reported in literature in the last decades were based 
on the previously proposed semiquantitative analysis of renal histology (Pirani & Salinas-
Madrigal, 1975).    
2.2.1 Remuzzi score   
The results of a consensus created by an international panel of pathologists (Remuzzi et al., 
1999) consented the creation of a new score, This method was presented for the evaluation 
of kidneys procured from donors older than 60 years of age. This new method quantified 
the number of nephrons for each kidney with the intent to estimate if the grafts should be 
available for KT and whether single or dual transplantation should be used. This panel 
suggested a biopsy-based score ranging from a minimum of 0 (indicating the absence of 
renal lesions) to a maximum of 12 (indicating the presence of marked changes in the renal 
parenchyma) (Table 2). 
The four different parameters considered in the scoring system were: 
Glomerular global sclerosis (0-3), tubular atrophy (0-3), interstitial fibrosis (0-3) and arterial and 
arteriolar narrowing (0-3).  
Kidneys with a score of 3 or lower were predicted to contain enough viable nephrons to be 
used as single transplants. Those with a score of 4, 5, or 6 could be used as dual transplants, 
on the assumption that the sum of the viable nephrons in the two kidneys approached the 
number in one ideal kidney. Kidneys with a score of 7 or greater were discarded, since it 
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was assumed that they would deliver an insufficient dose of nephrons, even in a dual 
transplantation. 
The validity of the score was tested (Remuzzi et al., 2006) analyzing a prospective cohort 
study of 62 patients who received one or two histologically evaluated kidneys from donors 
older than 60 years of age.  
The outcomes of these grafts were compared with the outcomes among 248 matched 
recipients of single kidney grafts that had not been histologically evaluated and were either 
from 124 donors with age ≤ 60 years or from 124 donors older than 60 years.  
 
Pretransplant biopsy protocol: semiquantitative method of evaluation of slides # 
Glomerular global sclerosis 
Based on three sections (the first, middle, and last sections, if available); the number of 
globally sclerosed glomerules expressed as a percentage. 
0   none globally sclerosed 
1+  < 20% global glomerulosclerosis 
2+  20 to 50% global glomerulosclerosis 
3+  > 50% global glomerulosclerosis 
Tubular atrophy 
0   absent 
1+  < 20% of tubuli affected 
2+  20 to 50% of tubuli affected 
3+  > 50% of tubuli affected 
Interstitial fibrosis 
0   absent 
1+  < 20% of renal tissue replaced by fibrous connective tissue 
2+  20 to 50% of renal tissue replaced by fibrous connective tissue 
3+  > 50% of renal tissue replaced by fibrous connective tissue 
Arterial and arteriolar narrowing 
For the vascular lesions, if the changes are focal, the most severe lesion present gives the 
final grade. 
0   absent 
1+  increased wall thickness but to a degree that is less than the diameter of the lumen 
2+  wall thickness that is equal or slightly greater to the diameter of the lumen 
3+  wall thickness that far exceeds the diameter of the lumen with extreme luminal 
narrowing or occlusion 
Final grade (range from 0 to a total of 12) 
0 to 3      mild           OK for single transplant 
4 to 6      moderate       OK for double transplant 
7 to 12     severe         should not be transplanted 
# Only biopsies with ≥ 25 glomerules considered for slide evaluation. Kidneys with evidence of acute 
tubular necrosis are not considered for the double transplant. Biopsies are graded as mild if they have 
0 to 3 points in total provided they are less than 3 in any one category. Biopsies are graded as 
moderate if they have 4 to 6 points in total provided they do not have 3 points in more than one 
category. 
 
Table 2. Histological score proposed by Remuzzi et al., 1999 (with modifications). 
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Analyzing long-term graft survival, excellent results were observed using the grafts 
previously selected by biopsy.  
Graft survival in recipients of histologically evaluated kidneys did not differ significantly 
from that of grafts from younger donors previously evaluated with biopsy. On the other 
side, survivals were strongly superior to that of elder grafts not pre-operatively evaluated 
with biopsy.  
Adopting this score, long-term survival of single or dual kidney grafts from donors older 
than 60 years of age were similarly excellent, showing that systematic hystological approach 
may help to expand the donor-organ pool for kidney transplantation without a 
contemporaneous lack of results . 
2.2.2 Karpinski score    
A New study based on histological aspects (Karpinski et al., 1999) was performed on 57 
allografts procured by 34 elderly donors (age ≥ 60 years) with hypertension and/or vascular 
disease.  
Graft survival of these patients was compared with the results of 57 control recipients 
selected to have similar baseline demographics but receiving transplants from younger 
donors.  
Donor renal pathology was scored 0-3 (none to severe disease) in four areas (Table 3):  
Glomerulosclerosis, tubular atrophy, interstitial fibrosis and vascular disease.  
Vascular disease was composed by two different parameters (e.g. arteriolar narrowing and arterial 
sclerosis).  
The number of sclerotic glomerules was expressed as a percent of the total number of 
glomerules available for evaluation.  
For the vascular lesions, both arteries were evaluated separately. However, for the final 
vascular score, the most severe lesion of either arterioles or arteries determined the final 
grade. Each of the 4 compartments was given a score from 0 to 3; the total score was 
expressed out of 12.  
A donor vessel score of 3/3 was associated with a 100% incidence of delayed graft function 
and poor 1-year graft function.  
2.3 Donor and histological graft variables   
A new model (Anglicheau et al., 2008) in which both histological and clinical variables were 
combined was developed in France. Before this study, in fact, a definitive role of pre-
implantation biopsies versus clinical scores had not been extensively studied in marginal 
donors. 
Pre-KT biopsies of 313 grafts from donors aged more than 50 years were analyzed.  
Authors evaluated the ability in predicting 1-year poor graft function (estimated glomerular 
filtration rate [eGFR] < 25 mL/min/1.73 m2) of several donor clinical and histological 
features. 
In multivariate analysis, the clinical and histological features that resulted statistically 
significant were: 
Clinical parameters = donor hypertension and a serum Creatinine level ≥150 lmol/L before organ 
recovery.  
Histological parameters: glomerulosclerosis, arteriolar hyalinosis, Pirani and CADI score.  
However, the model who presented the highest performance in predicting low eGFR was 
achieved using a composite score that included donor serum creatinine (≥150 lmol/L or 
<150 lmol/L), donor hypertension and glomerulosclerosis (≥10% or <10%) (Figure 7).  
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Pretransplant biopsy protocol: semiquantitative method of evaluation of slides # 
Glomerular wcore 
0   none globally sclerosed 
1+  < 20% global glomerulosclerosis 
2+  20 to 50% global glomerulosclerosis 
3+  > 50% global glomerulosclerosis 
Tubular score 
0   absent 
1+  < 20% of tubuli affected 
2+  20 to 50% of tubuli affected 
3+  > 50% of tubuli affected 
Interstitial score 
0   absent 
1+  < 20% of cortical parenchyma replaced by fibrous connective tissue 
2+  20 to 50% of cortical parenchyma replaced by fibrous connective tissue 
3+  > 50% of cortical parenchyma replaced by fibrous connective tissue 
Vascular score 
Arteriolar narrowing (or hyaline arteriolosclerosis)## 
0   absent 
1+  increased wall thickness but to a degree that is less than the diameter of the lumen 
2+  wall thickness that is equal or slightly greater to the diameter of the lumen 
3+  wall thickness that far exceeds the diameter of the lumen with extreme luminal 
narrowing or occlusion 
Arterial sclerosis (or intimal fibrous thickening-fibroplasia)## 
0   absent 
1+  increased wall thickness but to a degree that is less than the diameter of the lumen 
2+  wall thickness that is equal or slightly greater to the diameter of the lumen 
3+  wall thickness that far exceeds the diameter of the lumen with extreme luminal 
narrowing or occlusion 
# Only biopsies with at least 20 glomerules are considered for slide evaluation. ## For the vascular 
lesions, both arteries are evaluated separately. However, for the final vascular score, the most severe 
lesion of either arterioles or arterie determines the final grade.  
 
 
 
 
 
 
Table 3. Scoring system proposed by Karpinski et al., 1999 (with modifications). 
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Fig. 7. Receiver operating characteristics (ROC) curves for clinical, histopathological and 
composite scoring systems as predictors of low eGFR at 1-year posttransplant. Global test: p-
value = 0.007; composite score vs glomerulosclerosis: p-value = NS; composite score vs 
Pirani score: p-value = 0.001; composite score vs clinical parameters: p-value = 0.009). Taken 
from Anglicheau et al., 2008. 
3. Measures of early graft function   
Many measures of early graft function have been reported in Literature. Many of them were 
proposed with the intent to give a better definition of DGF. In fact, DGF is both an outcome 
and a predictor of the subsequent course of a renal transplant. Commonly adopted 
definition of DGF is the requirement for dialysis within the first week after KT (Daly et al., 
2005). However, postoperative requirement of dialysis represents a very subjective and not 
standardized clinical decision. Recently, efforts have been made to quantify DGF more 
scientifically, adopting different scores based on urine output, serum creatinine levels, fluid 
overload and uremic status of the patient.  
A comprehensive review of the literature (Yarlagadda et al., 2008) reported 18 different 
definitions for DGF (Table 4).  
 
Definitions No. of 
studies 
No. of 
patients 
Dialysis-based definitions 
Need for dialysis in the first week after transplant 41 259.251 
Need for dialysis in the first week after transplant once hyperacute 
rejection, vascular and urinary tract complications were ruled out 
2 760 
Need for dialysis after transplant 2 737 
Need for dialysis in the first 10 days after transplant 1 41 
Absence of life-sustaining renal function that requires dialysis on two 
or more occasions within the first week after transplant 
1 547 
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Definitions No. of 
studies 
No. of 
patients 
Need for dialysis in the first 7 days after transplant with specific 
exclusion of single early post-operative dialysis performed for 
hyperkalemia 
1 319 
Return to maintenance hemodialysis within the first 4 days after 
transplantation 
1 263 
Creatinine-based definitions 
Serum creatinine increased or remained unchanged or decreased 
<10%/day during 3 consecutive days after the transplant 
5 1471 
Creatinine reduction ratio <30% and /or urine creatinine on Day 2 
<1000 mg 
2 401 
Serum creatinine >2.5 mg/dL on Day 7 or the need for post-transplant 
hemodialysis 
1 99 
Time required for the kidney to reach Crcl>10 mL/min greater than 1 
week. 
1 843 
Failure of creatinine to decline in the first 48 h in the absence of 
rejection 
1 291 
Combination 
Failure of serum creatinine to fall below pre-transplant levels, within 1 
week regardless of the urine output 
1 158 
Patients with rise in serum Cr at 6–8 h post-operatively or <300 cc of 
urine despite adequate volume and diuretics 
1 143 
Dialysis requirement after transplant or a serum creatinine 150 
μmol/L at Day 8 
1 112 
Urine output <1 L in 24 h and <25% fall in serum creatinine from 
baseline in first 24 h post-transplant 
1 244 
Urine output <75 mL/h in first 48 h or failure of serum Cr to decrease 
by 10% in the first 48 h 
1 66 
Need for dialysis in the first week after transplant or failure of serum 
creatinine to decrease within 24 h after transplant 
1 104 
Table 4. Different DGF definitions. Taken from Yarlagadda et al., 2008 (with modifications). 
In the same study, 10 proposal of diagnostic technique to identify DGF were also proposed 
(Figure 8). Starting from these grounds, we have stratified the early measures of graft 
function in three different categories: creatinine-based definition, urine-based definition and 
combined definition. 
3.1 Creatinine-based definition   
a. Serum creatinine level of > 3 mg/dL on the fifth day after surgery (Humar et al., 2000). 
b. CCR2 and 24-h UC2 
This score was created (Govani et al., 2002) combining the creatinine reduction ratio 
between days 1 and 2 (CRR2) and the 24-h urinary creatinine levels at post-KT day 2 (UC2)  
Equation: CRR2(%) = ([Cr1–Cr2]×100)/Cr1). (Cr1 = serum creatinine level at post-KT day 1; Cr2 = 
serum creatinine level at post-KT day 2). 
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The cut-off value for poor function corresponded to a CCR2 ≤ 30%. 
c. CCR2 
CCR2 was also adopted (Rodrigo et al., 2004; Salahudeen et al., 2004) as unique criterion for 
the definition of early graft function. The reported Authors used the same threshold value of 
30%.  
d. CCR7 
Creatinine reduction ratio at day 7 (CCR7) (Johnston et al., 2007) was proposed as score of 
initial graft function.  
Equation: CRR7(%) = ([Cr0–Cr7]×100)/Cr0). (Cr0 = serum creatinine levels immediately before KT 
and no later than 6 hours after last dialysis; Cr7 = serum creatinine levels at post-KT day 7). 
The cut-off value for poor function corresponded to a CCR7 ≤ 70% (Figure 9). 
 
e. Number of days to achieve a creatinine clearance of > 10 mL/min, calculated by the 
Gault-Cockroft formula (Giral-Classe et al., 1998). 
f. Serum creatinine level increased, remained unchanged or decreased by less than 10% 
per day immediately after surgery during three consecutive days for > 1 week (Boom et 
al., 2000).  
 
 
 
 
 
 
 
Fig. 8. Different clinical conditions that present as early graft dysfunction. (A) Current 
definitions do not allow us to distinguish DGF from other causes of graft dysfunction. (B) 
With an improved definition and/or diagnostic technique patients with DGF can be 
correctly classified. Taken from Yarlagadda et al., 2008. 
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Fig. 9. Left: Decline in creatinine within 2 weeks post-KT. Right: graft survival curves. IGF: 
initial good function (CCR7 > 70%), DGF: delayed graft function (need for dialysis), SGF: 
scarce graft function (CCR7 ≤ 70% no dialysis). Taken from Johnston et al., 2007. 
3.2 Urine-based definition  
UO7 
Urine output at post-KT day 7 (UO7) was recently proposed (Lai et al., 2010).  
Equation: UO7 = total urine output on day 7 post-transplantation (mL)/weight (kg)/24 
hours.  
UO7 presented an elevated power for the prediction of 1-year graft function: at ROC 
analysis, UO7 presented an elevated area under the curve (0.811) (Figure 10). A cut-off value 
of 500 mL/24 h showed high sensitivity (98.5%). 
 
 
Fig. 10. ROC curves for post-KT day 1 urine output (UO1) and day 7 urine output (UO7) 
according to 1-year graft function (eGFR ≥ 30 mL/min/1.73 m2). Taken from Lai Q et al, 
2009.  
3.3 Combined definition  
a. Cr7 and UO1 
A score based on the combination of serum creatinine at post-KT day 7 (Cr7) and urine 
output at post-KT day 1(UO1) was proposed (Schnuelle et al., 2007). 
Equation: UO1 = total 1st postoperative day urine output (mL)/weight (kg)/24 hours. 
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Kaplan-Maier survival estimates indicated a threshold effect of UO1 and Cr7, which could 
dissect the risk of graft failure. The thresholds referring to the 2nd quintile corresponded to 
a UO1 > 630 ml and a Cr7 <2.5 mg/dl. Combination of both of the parameters predicted a 5-
year graft survival probability >90%, according to a hazard ratio of 0.21 (95% CI 0.09–0.46) 
(Figure 11).  
 
 
Fig. 11. Summary plot of 5-year graft survival estimates, by surrogates of early graft 
function as categorized by freedom from dialysis post-transplant, urine output exceeding 
630 ml post-transplant, decline of serum creatinine below 2.5 mg/dl during the 1st week, 
and the combination of the latter criteria. Survival curves of the respective controls not 
meeting these requirements are displayed in light-colored lines. Taken from Schnuelle et al., 
2007. 
b. A definition of DGF obtainable within 6 hours after KT was proposed (Gonwa et al., 
2002). It was based on a rising serum creatinine level above that before surgery or a 
urine output of < 300 mL within 6 h of transplantation, despite diuretics and adequate 
volume. Adoption of a very early definition of no-graft function was adopted with the 
intent to choose the correct immunosuppressive therapeutic approach to the patients.  
c. A new model for the definition of DGF was created (Halloran & Hunsicker, 2001) by the 
combination of urine output of < 1 L in the first 24 h or a decrease in serum creatinine of 
< 20-30%.   
d. DGF was recently defined (Lai et al., 2009) as the presence of one of the following 
conditions: at least 1-day persistent oligoanuria (≤ 500 mL/24 h) during the first week 
or an increased, unchanged, or decreased by ≤ 30% 7-day serum creatinine as compared 
with the pre-KT value. 
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4. Comparison among the scoring systems  
Many researches have been performed on the identification of pre- or early post-operative 
clinical predictors of graft function; however, the great majority of them were based on 
isolated studies, usually in the populations from which they were initially derived. 
Moreover, only a small number of papers have focalized on their attention on the 
comparison among the different scoring systems.  
For example, a previously reported study (Schold et al., 2005) compared preoperative scores 
(ECD, DDS and DRS), showing DRS was the best model for the prediction of graft survival 
at multivariable analysis. In the same period, another study (Nyberg et al., 2005) showed the 
superiority of DDS respect to ECD.  
The first comparative analysis of preoperative and early post-operative scores (Moore et al., 
2007) tested the ability of these clinical variables to predict suboptimal early function 
variably assessed by: DGF (dialysis requirement during the first week), DGF duration, slow 
graft function (creatinine > 3 mg/dl on day 5) and creatinine reduction ratio on day 2.   
Multiple regression analysis was performed on 217 consecutive renal transplant recipients: 
DGF nomogram, DDS and ECD were compared. All scoring systems showed associations 
with early graft function, although only DGF nomogram remained statistically significant in 
the multiple regression model. However, the overall utility of the DGF nomogram in DGF 
prediction was moderate.  
Two years later, a new comparative study (Moore et al., 2009) focalized on its attention on 
the role of pre- and post-KT models for the prediction of graft dysfunction: primary 
outcome measures were creatinine at 12 months and the development of chronic kidney 
disease stage 4T. The preoperative donor quality scores tested were: ECD, DDS, DRS and 
DGF nomogram: the postoperative early function measures were: dialysis requirement and 
duration; extended DGF according to Boom definition (Boom et al., 2000); Cr5, Cr7, CRR2, 
CRR7 and UO1.   
Among the donor scoring systems, DRS was best associated with subsequent 6-month and 
1-year allograft function. The study suggested a sort of “hierarchy”: DRS > ECD > DDS > 
DGF nonogram. 
These results could be explained by the different ways the scores were initially developed. 
For example, DGF nomogram was developed with regard to dialysis requiring DGF 
specifically, DDS was focalized on 6-month creatinine clearance, while DRS and ECD had 
graft failure as the end measure. The “granulated” complexity of DRS and DDS scores may 
explain their superiority above ECD. 
Among the early function measures, extended definition of DGF, Cr5 and dialysis duration 
showed greatest predictive power in the patient population overall and in the subgroups of 
patients who not required or required dialysis, respectively. DGF resulted superior to the 
standard DGF definition: however, its importance lied in the simultaneous comparison of 
donor scores and early postoperative renal function to assess the best “baseline” indicator 
for later allograft dysfunction (Figure 12). 
In another recent paper (Moore et al., 2010) dDGF (dialysis-based definition) and extDGF 
(extended; Boom et al., 2000) were compared (Figure 13). In the multivariable model, 
extDGF but not dDGF was significantly associated with graft failure (HR 1.47; p-value = 
0.02). Similar results were observed for overall graft failure. The utility of extDGF as an early 
marker of late poor allograft outcomes suggested superiority over the traditional and often 
subjective dialysis-based definition.  
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Fig. 12. (A) Kaplan-Meier survival curves for a combined variable of Donor Risk Score (DRS) 
and the extended definition of delayed graft function (extDGF) for time to stage 4T chronic 
kidney disease in all patients. (B) Kaplan-Meier survival curves for a combined variable of 
Donor Risk Score (DRS) and serum creatinine at day 5 (Cr5) for time to stage 4T chronic 
kidney disease in patients not requiring dialysis immediately postoperatively. Taken from 
Moore et al., 2009.  
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Fig. 13. Diagram shows distribution of early graft function. dDGF, dialysis-based definition 
of delayed graft function; fDGF (or extDGF), functional definition of delayed graft function. 
Taken from Moore et al., 2010.  
Among creatinine-based models, Cr5 represented the “best” marker of early graft function 
in patients who didn’t undergo a post-KT dialysis (Moore et al., 2009).  
Indeed, the influence of pre- or post-KT dialysis on creatinine measurements independent of 
allograft excretory function was too great a confounder to allow meaningful interpretation 
of these parameters also in dialyzed patients. 
Exclusive (Lai et al., 2010) or combined (Schnuelle et al., 2007) use of UO could be of some 
benefit in a better evaluation of these patients: however, more consistent large studies on 
this field are still required.  
No comparative studies among clinical and histological scores have been reported. Studies 
are needed for a better understanding of the effective role of histological features and its 
comparison with pre- and immediately post-KT variables.  
5. Conclusion  
Donor scores, histological scores and early postoperative measures of renal allograft 
function may be of clinical utility in assessing the risk for subsequent renal dysfunction. This 
has relevance to organ allocation policy and also to the clinical management of individuals 
in the early postoperative period. 
However, no one of the proposed criteria has still been internationally adopted.  
Probably, a combined score based on pre- and post-operative clinical features and 
histological aspects may offer improved prognostication for graft outcome.  
However, the first objective of a score must be its feasibility: its excessive “granulation” 
could transform it in a hardly adopted instrument in the care practice.   
New studies focalized on the validation of previously proposed scores or for the 
development of new prognostication models are still required. 
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